Merit Medical Systems MMSI Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 48.7%0.0pp | 48.7%+0.2pp | 48.5%+0.5pp | 47.9%+0.1pp | 47.8%+0.4pp | |
| Operating margin | 12.2%0.0pp | 12.2%+0.9pp | 11.3%0.0pp | 11.3%-0.3pp | 11.6%+0.1pp | |
| Net margin | 9%+0.6pp | 8.5%+0.5pp | 8%-0.3pp | 8.3%-0.5pp | 8.8%-0.1pp | |
| EBITDA margin | 20.2%-0.1pp | 20.3%+0.9pp | 19.5%+0.1pp | 19.3%-0.1pp | 19.4%+0.3pp | |
| Free cash flow margin | 14.3%+0.1pp | 14.2%+0.2pp | 14%+0.6pp | 13.4%+0.4pp | 13%-0.7pp | |
| Returns | ||||||
| Return on equity | 9.1%+0.5pp | 8.7%+0.4pp | 8.3%-0.3pp | 8.6%-0.6pp | 9.2%-0.2pp | |
| Return on assets | 5.4%+0.3pp | 5%+0.3pp | 4.7%-0.1pp | 4.8%-0.3pp | 5.1%0.0pp | |
| Return on invested capital | 7.4%0.0pp | 7.4%+0.2pp | 7.2%-0.1pp | 7.3%-0.3pp | 7.6%0.0pp | |
| Efficiency | ||||||
| Asset turnover | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | |
| Inventory turnover | 2.4×-0.1× | 2.4×0.0× | 2.4×0.0× | 2.4×+0.1× | 2.3×0.0× | |
| Liquidity | ||||||
| Current ratio | 5.1×+0.7× | 4.3×+0.1× | 4.3×+0.2× | 4.1×-0.8× | 4.9×+0.6× | |
| Quick ratio | 3.5×+0.5× | 2.9×+0.1× | 2.9×+0.2× | 2.7×-0.6× | 3.3×+0.4× | |
| Cash ratio | 2.3×+0.4× | 1.9×+0.2× | 1.7×+0.2× | 1.5×-0.5× | 2×+0.3× | |
| Leverage | ||||||
| Debt-to-equity | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | 0.6×0.0× | 0.6×0.0× | |
| Debt-to-assets | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Net debt / EBITDA | 1.1×-0.2× | 1.2×-0.3× | 1.5×-0.2× | 1.7×+0.2× | 1.6×0.0× | |
| Interest coverage | 7.1×+0.1× | 7×+1.0× | 5.9×+0.3× | 5.6×+0.2× | 5.4×+0.4× | |
| Per Share | ||||||
| Book value per share | $27.11+3.4% | $26.20+2.7% | $25.52+4.0% | $24.55+5.3% | $23.31+0.3% | |
| Valuation | ||||||
| Market capitalization | $4.1B-21.6% | $5.23B+6.0% | $4.93B-10.6% | $5.51B-11.4% | $6.22B+10.3% | |
| Enterprise value | $4.43B-20.9% | $5.6B+4.5% | $5.36B-10.6% | $5.99B-9.8% | $6.64B+9.7% | |
| Price / earnings | 29.4×-11.3× | 40.7×-0.9× | 41.6×-4.7× | 46.3×-4.6× | 50.9×+4.0× | |
| Price / sales | 2.7×-0.8× | 3.4×+0.1× | 3.3×-0.5× | 3.8×-0.6× | 4.5×+0.3× | |
| Price / book | 2.5×-0.8× | 3.3×+0.1× | 3.2×-0.5× | 3.7×-0.7× | 4.4×+0.3× | |
| EV / EBITDA | 14.2×-4.0× | 18.2×-0.5× | 18.6×-3.0× | 21.6×-3.1× | 24.7×+1.2× | |
| EV / sales | 2.9×-0.8× | 3.7×+0.1× | 3.6×-0.6× | 4.2×-0.6× | 4.8×+0.3× | |
| Free cash flow yield | 5.4%+1.3pp | 4.1%-0.1pp | 4.2%+0.7pp | 3.5%+0.6pp | 2.9%-0.4pp | |
| Earnings yield | 3.4%+0.9pp | 2.5%+0.1pp | 2.4%+0.2pp | 2.2%+0.2pp | 2%-0.2pp | |
| PEG ratio | 2.1×-3.9× | 6×— | —— | 32.2×+29.6× | 2.6×+0.8× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Merit Medical Systems's profit margins?
- Merit Medical Systems (MMSI) runs a 48.7% gross margin and a 12.2% operating margin, with a 9.0% net margin.
- Where do Merit Medical Systems's ratios come from?
- Every ratio is computed from Merit Medical Systems's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.